Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Boryung Pharmaceutical Co., Ltd. Appoints New Co-CEO

Monday, 18 Mar 2013 02:25am EDT 

Boryung Pharmaceutical Co., Ltd. announced that it has appointed Choi Tae Hong as its new Co-Chief Executive Officer (Co-CEO), replacing Kim Gwang Ho, effective March 18, 2013. The current Co-CEO, Kim Eun Seon, continues his duty as Co-CEO at the Company. 

Company Quote

300.0 +0.71%
24 Oct 2014